
Since 1995, more than 180 species have had their entire genomes sequenced, including the human (Homo sapien). These projects have provided valuable insight into human evolution by comparing our genomes to other species, but have also aided biomedical research which uses model species in research, such as the laboratory mouse (Mus musculus), the laboratory rat (Rattus norvegicus), the nematode (Caenorhabditis elegans), the mustard plant (Arabidopsis thaliana), and the fruit fly (Drosophila melanogaster) - all of which have been completely sequenced.
Our genomes consist of the entire sequence of DNA bases (those As, Cs, Ts, and Gs) we have in the nuclei of each of our body's cells, including those pesky regions which differ even within a species (ie: SNPs, or single nucleotide polymorphisms, where just one base differs and can have a functional, and possibly detrimental, result). These DNA sequences are the blueprint for our development, and the starting point for the majority of our functions and behaviors.
Recently, the Genome 10K project was launched, with the goal of sequencing 10,000 genomes - a feat that not so long ago would have seemed impossible, but today appears feasible due to the improvement and decreased cost of DNA sequencing technology.
From the project's website:
The Genome 10K project aims to assemble a genomic zoo—a collection of DNA sequences representing the genomes of 10,000 vertebrate species, approximately one for every vertebrate genus. The trajectory of cost reduction in DNA sequencing suggests that this project will be feasible within a few years. Capturing the genetic diversity of vertebrate species would create an unprecedented resource for the life sciences and for worldwide conservation efforts.
The growing Genome 10K Community of Scientists (G10KCOS), made up of leading scientists representing major zoos, museums, research centers, and universities around the world, is dedicated to coordinating efforts in tissue specimen collection that will lay the groundwork for a large-scale sequencing and analysis project.
Why do this?
An excerpt from Science Magazine's coverage:
Ever since they finished the human genome sequence {in April 2003}, researchers have been champing at the bit to sequence other genomes to compare with human DNA. Such comparisons help identify conserved regions that likely serve key roles in survival and also regions that differ between species and likely represent adaptations to a particular way of life.
For example, research in comparative genomics has shown that the human and the fruit fly share 60% identity in their DNA sequences. A full 2/3 of human genes known to be involved in cancer have homologs in the fruit fly, making cancer research faster and easier by using a model species. In addition to providing novel information about human DNA and the functional implications of its sequence in physiology and disease, this project could also aid conservation efforts for endangered and dwindling species.
Implications
The decreased cost of DNA sequencing has also brought us into the era of personalized medicine and personal DNA testing kits. Pharmacogenomics is one area of personalized medicine hoping to take advantage of our inherited differences in DNA sequence, which may predispose us to respond better or worse to pharmacological treatments for disease.
Personal DNA testing, however, runs the gamut from research-driven (the Personal Genome Project) to purely a fee-for-service approach (ie: 23 and Me, named for our 23 pairs of chromosomes). And then we get into the realm of ethics, and whether the ability to determine SNPs that may predispose us to a disease leads to a necessity to know this information...but that is a post for another time!
References:
Sequencing:
Genome 10K: http://www.genome10k.org/
Science coverage of 10K: http://www.sciencemag.org/cgi/content/full/326/5954/794
Quick Guide to the sequenced genomes so far...
http://www.genomenewsnetwork.org/resources/sequenced_genomes/genome_guide_p1.shtml
Brief guide to genomics:
http://www.genome.gov (see Fact Sheets)
Also see my post on the 2009 Nobel Prize, relating to DNA:
http://open.salon.com/blog/aliquot/2009/10/19/a_science_nobel_prize_explained
Pharmacogenomics introduction from the Mayo Clinic:
http://www.mayoclinic.com/health/personalized-medicine/CA00078
Personalized DNA testing:
Intro from Nova (PBS):
http://www.pbs.org/wgbh/nova/sciencenow/0302/01.html
Personal Genome Project:
http://www.personalgenomes.org/
23 and Me:
https://www.23andme.com/


Salon.com
Comments
I do see the value in sequencing other species, I just think they aren't thinking large enough :)
Personally, I agree that this is a no brainer, though!
critique of personal genome services by New Scientist:
http://www.newscientist.com/article/dn17939-personal-genomics-firms-must-come-clean.html
Steven Pinker's personal genomics piece in the NYTimes:
http://www.nytimes.com/2009/01/11/magazine/11Genome-t.html?pagewanted=all